BioCentury
ARTICLE | Strategy

non-cardiac surgery

April 19, 1993 7:00 AM UTC

Dennis Mangano, a professor of anesthesiology at the University of California in San Francisco, suggests that a big growth area for cardiovascular drugs will be use in non-cardiac surgery.

About 25 million patients undergo non-cardiac surgery annually, of which 8 million have coronary disease risk factors or are over age 65. Morbidity is more than 1 million patients per year and the cost is more than $10 billion in hospital and $12 billion out of hospital, according to Mangano. ...